ArticleNeurology and therapy2022

Circulating Insulin-Like Growth Factor 1 Levels and Migraine Risk: A Mendelian Randomization Study.

Reziya Abuduxukuer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.